04/10/2020 10:58 AM EDT |
Neuro-oncologist Marta Penas-Prado, M.D., shares information about clinical trials at NIH investigating the effectiveness of an immunotherapy drug to treat people with rare brain and spine tumors. She explains the goals of the trials, who can participate and how, and what patients can expect. Learn more at www.cancer.gov/clinicaltrials/ |
lunes, 13 de abril de 2020
Immunotherapy Clinical Trials to Treat Brain and Spine Tumors
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario